ROIV

Roivant Sciences
D

ROIV

Arincen25/100B
40.640
USD
-0.02
(-0.05%)
Market Open
Last updated: · Delayed 15 min
Q2 FY2027 results
EPS-0.27+26.4%Revenue35.12M+710.0%
OverviewFinancialsForecastEarningsCompany

Roivant Sciences price to sales (P/S) ratio

Roivant Sciences's P/S ratio is 714.55: its market cap of 29.36B USD over revenue of 41.08M USD in the last twelve months.

Today
714.55
Average, 5 years
1,200.99
Low, 5 years
70.87
High, 5 years
4,000.54

P/S ratio = market cap ÷ revenue (last 12 months) = 29.36B ÷ 41.08M = 714.55

Each day's market cap over the revenue of the last four quarters reported by that day.

P/S ratio by year and by quarter

Fiscal yearPeriod endingP/S ratioMarket capRevenue
Today714.5529.36B41.08M
FY202531 Mar 20262,326.8819.22B8.26M
FY202431 Mar 2025251.937.32B29.05M
FY202331 Mar 2024249.738.17B32.71M
FY202231 Mar 2023166.845.26B31.53M
FY202131 Mar 202259.843.31B55.29M
FY202031 Mar 2021281.466.70B23.80M
FY201931 Mar 2020105.217.12B67.69M

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.

See also:Market cap,ROE (return on equity),Debt to equity,Current ratio,All ratios

Common questions about Roivant Sciences's P/S ratio

Source: Financial Modeling Prep

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.